Evidence map›Paper›PMID 39772623›Full record

ArticleJournal of virology2025

HCMV infection downregulates GPX4 and stimulates lipid peroxidation but does not induce ferroptosis.

Madison Martin, Rinki Kumar, Nicholas J Buchkovich, Christopher C Norbury

Abstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Human cytomegalovirus promotesJournal of virology · 2025
    Article
  3. Cancers · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Madison MartinDepartment of Microbiology and Immunology, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Rinki KumarDepartment of Microbiology and Immunology, Penn State College of Medicine, Hershey, Pennsylvania, USA.ORCID 0000-0002-2087-3226
Nicholas J BuchkovichDepartment of Microbiology and Immunology, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Christopher C NorburyDepartment of Microbiology and Immunology, Penn State College of Medicine, Hershey, Pennsylvania, USA.ORCID 0000-0001-7411-6987

Funding

Analysis of the mechanism of HCMV cytoplasmic envelopmentR01AI130156 · NIAID · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI Christopher C Norbury · 2017 to 2026
$3.8M
How does Cytomegalovirus use interferon lambda for optimal spreadR21AI169180 · NIAID · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI NORBURY, CHRISTOPHER C · 2022 to 2023
$446k
The effect of local virus infection upon cutaneous wound healing: the impact of virus-induced Type III IFNsR21AR077778 · NIAMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI NORBURY, CHRISTOPHER C · 2021 to 2022
$390k
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R21AI169180,R01AI130156HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) AR077778NIAID NIH HHS R01 AI130156NIAID NIH HHS R21 AI169180NIAMS NIH HHS R21 AR077778
6 · The paper itself

Abstract

Human cytomegalovirus (HCMV) modulates numerous cellular pathways to facilitate infection, including key components in cellular iron homeostasis. Iron is essential to many cellular processes but, if present in excess, drives cell death through ferroptosis. Ferroptosis is a process that is dependent upon the accumulation of oxidatively damaged phospholipids (lipid peroxides); when these lipid peroxides accumulate in membranes, this culminates in plasma membrane rupture and eventual cell lysis. Here, we demonstrate that HCMV infection downregulates the expression of a key modulator of lipid peroxidation, glutathione peroxidase 4 (GPX4). HCMV infection also markedly increased levels of lipid peroxides within infected cells. Despite the marked downregulation of GPX4 by HCMV, further inhibition of GPX4 impaired virus replication. Interestingly, overexpression of GPX4 did not reduce the production of lipid peroxides within infected cells. In contrast, lipid peroxide levels were reduced by treatment with ferrostatin-1, a ferrous iron-dependent scavenger of alkoxyl radicals, indicating a role for iron in the production of lipid peroxides. HCMV-infected cells became less sensitive to GPX4 inhibition as infection progressed, requiring substantially higher levels of GPX4 inhibitors to induce ferroptosis compared to uninfected cells. This observed difference in sensitivity to ferroptosis upon infection correlated with a large increase in lipid production by infected cells. Therefore, the marked stimulation of lipid peroxidation by HCMV likely proceeds through a pathway that is independent of GPX4 regulation, but the ability of lipid peroxides to stimulate ferroptosis by modulating plasma membrane rupture is likely blunted by the massive increase in lipid production during HCMV infection. IMPORTANCE: Human cytomegalovirus (HCMV) infection is intimately linked with countless host cell pathways that are modulated in a coordinated fashion to facilitate infection. Here, we describe HCMV-induced regulation of lipid peroxidation, a precursor of the iron-regulated cell death pathway known as ferroptosis, during human cytomegalovirus infection. These studies reveal hitherto unidentified changes in metabolism mediated by HCMV that decrease sensitivity to ferroptosis, despite increases in lipid peroxidation and transient increases in intracellular iron levels in infected cells.

Indexed as

CytomegalovirusCytomegalovirus InfectionsFerroptosisLipid PeroxidationPhospholipid Hydroperoxide Glutathione PeroxidaseCell LineDown-RegulationHumansIronLipid PeroxidesPhenylenediaminesVirus ReplicationIronLipid PeroxidesPhenylenediaminesPhospholipid Hydroperoxide Glutathione PeroxidaseferroptosisHCMVironlipid peroxides

Identifiers

PMID39772623
PMCPMC11852782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.